November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at email@example.com)
May 25, 2013
Russian Embassy to Ukraine has not yet received Consul Andreyev's resignation
At least 13 hurt in Makhachkala bombing - update
Interpol's refusal to search for Browder is decision made under pressure - Duma deputy (Part 2)
Russian state TV cameraman hurt in Makhachkala bombing
Yanukovych could attend Customs Union summit in Astana on May 29 - Russian ambassador in Kyiv
Ilya Ponomaryov urged to return money "received dishonestly" to Skolkovo Foundation
Numerous opportunities exist to settle problem of Azeri oil delivery to Russia - diplomat
Criminal case opened into Makhachkala bomb attack
Bomb used in Makhachkala attack was equivalent to about 500 g of TNT - National Antiterrorist Committee
EXPLOSIVE BELT USED BY SUICIDE ATTACKER IN MAKHACHKALA WAS EQUIVALENT TO ABOUT 500 GRAMS OF TNT - NATIONAL ANTITERRORIST COMMITTEE
Passengers from Boeing that made emergency landing in Moscow provided with another plane
Russia has not yet sent documents to Interpol on declaring Browder wanted - Interior Ministry
U.S. contented with outcomes of Russian Security Council Secretary Patrushev's visit - Gottemoeller (Part 2)
UN Secretary General Ban Ki-moon has given an interview to Interfax ahead of his visit to Russia on May 16-19 in which he speaks about the goals of his visit, pressing tasks that the UN face, the organization‘s reform, as well as topical issues on the international agenda, including situation in Syria and the Middle East settlement.
Deputy NATO Secretary General Alexander Vershbow, who is visiting Moscow for an informal conference of former U.S. ambassadors to Russia and Russian ambassador to the United States, has given an interview to Interfax in which he speaks about NATO-Russia cooperation, as well as pressing issues on the international agenda, such as the missile defense issue, North Korea, Syria and Afghanistan.
British Foreign Secretary William Hague has given an interview to Interfax‘ journalist Olga Golovanova ahead of the 2+2 meeting slated for March 13 in London, on which he speaks about the agenda of the upcoming 2+2 talks, the whole range of British-Russian relations, including human rights, as well as pressing international issues notably Syria.